Global Genital Herpes Treatment Drug Production, Demand and Key Producers, 2022-2028
This report studies the global Genital Herpes Treatment Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Genital Herpes Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genital Herpes Treatment Drug that contribute to its increasing demand across many markets.
The global Genital Herpes Treatment Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Genital Herpes Treatment Drug total market, 2017-2028, (USD Million)
Global Genital Herpes Treatment Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Genital Herpes Treatment Drug total market, key domestic companies and share, (USD Million)
Global Genital Herpes Treatment Drug revenue by player and market share 2017-2022, (USD Million)
Global Genital Herpes Treatment Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Genital Herpes Treatment Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Genital Herpes Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi, Avet Pharmaceuticals Inc., Carlsbad Tech, Glenmark Pharmaceuticals Inc., Zydus Pharmaceuticals, Mylan Pharmaceutcials Inc., Apotex Inc., Epi Health LLC and AiCuris Anti-infective Cures GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genital Herpes Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Genital Herpes Treatment Drug Market, By Region:
1. How big is the global Genital Herpes Treatment Drug market?
2. What is the demand of the global Genital Herpes Treatment Drug market?
3. What is the year over year growth of the global Genital Herpes Treatment Drug market?
4. What is the total value of the global Genital Herpes Treatment Drug market?
5. Who are the major players in the global Genital Herpes Treatment Drug market?
6. What are the growth factors driving the market demand?
This report is a detailed and comprehensive analysis of the world market for Genital Herpes Treatment Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Genital Herpes Treatment Drug that contribute to its increasing demand across many markets.
The global Genital Herpes Treatment Drug market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).
Highlights and key features of the study
Global Genital Herpes Treatment Drug total market, 2017-2028, (USD Million)
Global Genital Herpes Treatment Drug total market by region & country, CAGR, 2017-2028, (USD Million)
U.S. VS China: Genital Herpes Treatment Drug total market, key domestic companies and share, (USD Million)
Global Genital Herpes Treatment Drug revenue by player and market share 2017-2022, (USD Million)
Global Genital Herpes Treatment Drug total market by Type, CAGR, 2017-2028, (USD Million)
Global Genital Herpes Treatment Drug total market by Application, CAGR, 2017-2028, (USD Million)
This reports profiles major players in the global Genital Herpes Treatment Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fresenius Kabi, Avet Pharmaceuticals Inc., Carlsbad Tech, Glenmark Pharmaceuticals Inc., Zydus Pharmaceuticals, Mylan Pharmaceutcials Inc., Apotex Inc., Epi Health LLC and AiCuris Anti-infective Cures GmbH, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Genital Herpes Treatment Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.
Global Genital Herpes Treatment Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Acyclovir (Zovirax)
- Famciclovir (Famvir)
- Valacyclovir (Valtrex)
- Others
- Hospital
- Clinic
- Others
- Fresenius Kabi
- Avet Pharmaceuticals Inc.
- Carlsbad Tech
- Glenmark Pharmaceuticals Inc.
- Zydus Pharmaceuticals
- Mylan Pharmaceutcials Inc.
- Apotex Inc.
- Epi Health LLC
- AiCuris Anti-infective Cures GmbH
- Chimerix
- Admedus
- Sanofi Pasteur SA
- Maruho Co. Ltd.
- F.Hoffmann-La Roche Ltd.
- Novartis AG
- Merck & Co. Inc.
- GlaxoSmithKline Plc
1. How big is the global Genital Herpes Treatment Drug market?
2. What is the demand of the global Genital Herpes Treatment Drug market?
3. What is the year over year growth of the global Genital Herpes Treatment Drug market?
4. What is the total value of the global Genital Herpes Treatment Drug market?
5. Who are the major players in the global Genital Herpes Treatment Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Genital Herpes Treatment Drug Introduction
1.2 World Genital Herpes Treatment Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Genital Herpes Treatment Drug Total Market by Region
1.3.1 World Genital Herpes Treatment Drug Market Size by Region (2017-2028)
1.3.2 United States Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.3 China Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.4 Europe Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.5 Japan Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.6 South Korea Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.7 ASEAN Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.8 India Genital Herpes Treatment Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genital Herpes Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genital Herpes Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD GENITAL HERPES TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Genital Herpes Treatment Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Genital Herpes Treatment Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Genital Herpes Treatment Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Genital Herpes Treatment Drug in 2021
2.3 Genital Herpes Treatment Drug Company Evaluation Quadrant
2.4 Genital Herpes Treatment Drug Market: Overall Company Footprint Analysis
2.4.1 Genital Herpes Treatment Drug Market: Region Footprint
2.4.2 Genital Herpes Treatment Drug Market: Company Product Type Footprint
2.4.3 Genital Herpes Treatment Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Genital Herpes Treatment Drug Market Comparison
3.1.1 United States VS China: Genital Herpes Treatment Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Genital Herpes Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Genital Herpes Treatment Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Genital Herpes Treatment Drug in United States, Headquarters (States, Country)
3.2.2 United States Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022)
3.3 China Genital Herpes Treatment Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Genital Herpes Treatment Drug in China, Headquarters (Province, Country)
3.3.2 China Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Genital Herpes Treatment Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Genital Herpes Treatment Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Genital Herpes Treatment Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Acyclovir (Zovirax)
4.2.2 Famciclovir (Famvir)
4.2.3 Valacyclovir (Valtrex)
4.2.4 Others
4.3 Market Segment by Type
4.3.1 World Genital Herpes Treatment Drug Market Size by Type (2017-2022)
4.3.2 World Genital Herpes Treatment Drug Market Size by Type (2023-2028)
4.3.3 World Genital Herpes Treatment Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Genital Herpes Treatment Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital
5.2.2 Clinic
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Genital Herpes Treatment Drug Market Size by Application (2017-2022)
5.3.2 World Genital Herpes Treatment Drug Market Size by Application (2023-2028)
5.3.3 World Genital Herpes Treatment Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Details
6.1.2 Fresenius Kabi Major Business
6.1.3 Fresenius Kabi Genital Herpes Treatment Drug Product and Services
6.1.4 Fresenius Kabi Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Fresenius Kabi Recent Developments/Updates
6.1.6 Fresenius Kabi Competitive Strengths & Weaknesses
6.2 Avet Pharmaceuticals Inc.
6.2.1 Avet Pharmaceuticals Inc. Details
6.2.2 Avet Pharmaceuticals Inc. Major Business
6.2.3 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
6.2.4 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Avet Pharmaceuticals Inc. Recent Developments/Updates
6.2.6 Avet Pharmaceuticals Inc. Competitive Strengths & Weaknesses
6.3 Carlsbad Tech
6.3.1 Carlsbad Tech Details
6.3.2 Carlsbad Tech Major Business
6.3.3 Carlsbad Tech Genital Herpes Treatment Drug Product and Services
6.3.4 Carlsbad Tech Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Carlsbad Tech Recent Developments/Updates
6.3.6 Carlsbad Tech Competitive Strengths & Weaknesses
6.4 Glenmark Pharmaceuticals Inc.
6.4.1 Glenmark Pharmaceuticals Inc. Details
6.4.2 Glenmark Pharmaceuticals Inc. Major Business
6.4.3 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
6.4.4 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
6.4.6 Glenmark Pharmaceuticals Inc. Competitive Strengths & Weaknesses
6.5 Zydus Pharmaceuticals
6.5.1 Zydus Pharmaceuticals Details
6.5.2 Zydus Pharmaceuticals Major Business
6.5.3 Zydus Pharmaceuticals Genital Herpes Treatment Drug Product and Services
6.5.4 Zydus Pharmaceuticals Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Zydus Pharmaceuticals Recent Developments/Updates
6.5.6 Zydus Pharmaceuticals Competitive Strengths & Weaknesses
6.6 Mylan Pharmaceutcials Inc.
6.6.1 Mylan Pharmaceutcials Inc. Details
6.6.2 Mylan Pharmaceutcials Inc. Major Business
6.6.3 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product and Services
6.6.4 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Mylan Pharmaceutcials Inc. Recent Developments/Updates
6.6.6 Mylan Pharmaceutcials Inc. Competitive Strengths & Weaknesses
6.7 Apotex Inc.
6.7.1 Apotex Inc. Details
6.7.2 Apotex Inc. Major Business
6.7.3 Apotex Inc. Genital Herpes Treatment Drug Product and Services
6.7.4 Apotex Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Apotex Inc. Recent Developments/Updates
6.7.6 Apotex Inc. Competitive Strengths & Weaknesses
6.8 Epi Health LLC
6.8.1 Epi Health LLC Details
6.8.2 Epi Health LLC Major Business
6.8.3 Epi Health LLC Genital Herpes Treatment Drug Product and Services
6.8.4 Epi Health LLC Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Epi Health LLC Recent Developments/Updates
6.8.6 Epi Health LLC Competitive Strengths & Weaknesses
6.9 AiCuris Anti-infective Cures GmbH
6.9.1 AiCuris Anti-infective Cures GmbH Details
6.9.2 AiCuris Anti-infective Cures GmbH Major Business
6.9.3 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product and Services
6.9.4 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 AiCuris Anti-infective Cures GmbH Recent Developments/Updates
6.9.6 AiCuris Anti-infective Cures GmbH Competitive Strengths & Weaknesses
6.10 Chimerix
6.10.1 Chimerix Details
6.10.2 Chimerix Major Business
6.10.3 Chimerix Genital Herpes Treatment Drug Product and Services
6.10.4 Chimerix Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Chimerix Recent Developments/Updates
6.10.6 Chimerix Competitive Strengths & Weaknesses
6.11 Admedus
6.11.1 Admedus Details
6.11.2 Admedus Major Business
6.11.3 Admedus Genital Herpes Treatment Drug Product and Services
6.11.4 Admedus Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Admedus Recent Developments/Updates
6.11.6 Admedus Competitive Strengths & Weaknesses
6.12 Sanofi Pasteur SA
6.12.1 Sanofi Pasteur SA Details
6.12.2 Sanofi Pasteur SA Major Business
6.12.3 Sanofi Pasteur SA Genital Herpes Treatment Drug Product and Services
6.12.4 Sanofi Pasteur SA Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Sanofi Pasteur SA Recent Developments/Updates
6.12.6 Sanofi Pasteur SA Competitive Strengths & Weaknesses
6.13 Maruho Co. Ltd.
6.13.1 Maruho Co. Ltd. Details
6.13.2 Maruho Co. Ltd. Major Business
6.13.3 Maruho Co. Ltd. Genital Herpes Treatment Drug Product and Services
6.13.4 Maruho Co. Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Maruho Co. Ltd. Recent Developments/Updates
6.13.6 Maruho Co. Ltd. Competitive Strengths & Weaknesses
6.14 F.Hoffmann-La Roche Ltd.
6.14.1 F.Hoffmann-La Roche Ltd. Details
6.14.2 F.Hoffmann-La Roche Ltd. Major Business
6.14.3 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Product and Services
6.14.4 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates
6.14.6 F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
6.15 Novartis AG
6.15.1 Novartis AG Details
6.15.2 Novartis AG Major Business
6.15.3 Novartis AG Genital Herpes Treatment Drug Product and Services
6.15.4 Novartis AG Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Novartis AG Recent Developments/Updates
6.15.6 Novartis AG Competitive Strengths & Weaknesses
6.16 Merck & Co. Inc.
6.16.1 Merck & Co. Inc. Details
6.16.2 Merck & Co. Inc. Major Business
6.16.3 Merck & Co. Inc. Genital Herpes Treatment Drug Product and Services
6.16.4 Merck & Co. Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Merck & Co. Inc. Recent Developments/Updates
6.16.6 Merck & Co. Inc. Competitive Strengths & Weaknesses
6.17 GlaxoSmithKline Plc
6.17.1 GlaxoSmithKline Plc Details
6.17.2 GlaxoSmithKline Plc Major Business
6.17.3 GlaxoSmithKline Plc Genital Herpes Treatment Drug Product and Services
6.17.4 GlaxoSmithKline Plc Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 GlaxoSmithKline Plc Recent Developments/Updates
6.17.6 GlaxoSmithKline Plc Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Genital Herpes Treatment Drug and Key Manufacturers
7.2 Genital Herpes Treatment Drug Manufacturing Costs
7.3 Genital Herpes Treatment Drug Production Process
7.4 Genital Herpes Treatment Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Genital Herpes Treatment Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Genital Herpes Treatment Drug Typical Distributors
8.3 Genital Herpes Treatment Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Genital Herpes Treatment Drug Introduction
1.2 World Genital Herpes Treatment Drug Market Size & Forecast (2017 & 2021 & 2028)
1.3 World Genital Herpes Treatment Drug Total Market by Region
1.3.1 World Genital Herpes Treatment Drug Market Size by Region (2017-2028)
1.3.2 United States Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.3 China Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.4 Europe Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.5 Japan Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.6 South Korea Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.7 ASEAN Genital Herpes Treatment Drug Market Size (2017-2028)
1.3.8 India Genital Herpes Treatment Drug Market Size (2017-2028)
1.4 Market Drivers, Restraints and Trends
1.4.1 Genital Herpes Treatment Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Genital Herpes Treatment Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 WORLD GENITAL HERPES TREATMENT DRUG COMPANIES COMPETITIVE ANALYSIS
2.1 World Genital Herpes Treatment Drug Revenue by Player (2017-2022)
2.2 Industry Rank and Concentration Rate (CR)
2.2.1 Global Genital Herpes Treatment Drug Industry Rank of Major Players
2.2.2 Global Concentration Ratios (CR4) for Genital Herpes Treatment Drug in 2021
2.2.3 Global Concentration Ratios (CR8) for Genital Herpes Treatment Drug in 2021
2.3 Genital Herpes Treatment Drug Company Evaluation Quadrant
2.4 Genital Herpes Treatment Drug Market: Overall Company Footprint Analysis
2.4.1 Genital Herpes Treatment Drug Market: Region Footprint
2.4.2 Genital Herpes Treatment Drug Market: Company Product Type Footprint
2.4.3 Genital Herpes Treatment Drug Market: Company Product Application Footprint
2.5 Competitive Environment
2.5.1 Historical Structure of the Industry
2.5.2 Barriers of Market Entry
2.5.3 Factors of Competition
2.6 Mergers, Acquisitions Activity
3 UNITED STATES VS CHINA VS REST OF THE WORLD
3.1 United States VS China: Genital Herpes Treatment Drug Market Comparison
3.1.1 United States VS China: Genital Herpes Treatment Drug Market Size Comparison (2017 & 2021 & 2028)
3.1.2 United States VS China: Genital Herpes Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
3.2 United States Genital Herpes Treatment Drug Major Players and Market Share, 2017-2022
3.2.1 Major Players of Genital Herpes Treatment Drug in United States, Headquarters (States, Country)
3.2.2 United States Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022)
3.3 China Genital Herpes Treatment Drug Major Players and Market Share, 2017-2022
3.3.1 Major Players of Genital Herpes Treatment Drug in China, Headquarters (Province, Country)
3.3.2 China Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022)
3.4 Rest of World Genital Herpes Treatment Drug Major Players and Market Share, 2017-2022
3.4.1 Major Players of Genital Herpes Treatment Drug in Rest of World, Headquarters (State, Country)
3.4.2 Rest of World Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022)
4 MARKET ANALYSIS BY TYPE
4.1 World Genital Herpes Treatment Drug Market Size Overview by Type: 2017 VS 2021 VS 2028
4.2 Segment Introduction by Type
4.2.1 Acyclovir (Zovirax)
4.2.2 Famciclovir (Famvir)
4.2.3 Valacyclovir (Valtrex)
4.2.4 Others
4.3 Market Segment by Type
4.3.1 World Genital Herpes Treatment Drug Market Size by Type (2017-2022)
4.3.2 World Genital Herpes Treatment Drug Market Size by Type (2023-2028)
4.3.3 World Genital Herpes Treatment Drug Market Size Market Share by Type (2017-2028)
5 MARKET ANALYSIS BY APPLICATION
5.1 World Genital Herpes Treatment Drug Market Size Overview by Application: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Application
5.2.1 Hospital
5.2.2 Clinic
5.2.3 Others
5.3 Market Segment by Application
5.3.1 World Genital Herpes Treatment Drug Market Size by Application (2017-2022)
5.3.2 World Genital Herpes Treatment Drug Market Size by Application (2023-2028)
5.3.3 World Genital Herpes Treatment Drug Market Size by Application (2017-2028)
6 COMPANY PROFILES
6.1 Fresenius Kabi
6.1.1 Fresenius Kabi Details
6.1.2 Fresenius Kabi Major Business
6.1.3 Fresenius Kabi Genital Herpes Treatment Drug Product and Services
6.1.4 Fresenius Kabi Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.1.5 Fresenius Kabi Recent Developments/Updates
6.1.6 Fresenius Kabi Competitive Strengths & Weaknesses
6.2 Avet Pharmaceuticals Inc.
6.2.1 Avet Pharmaceuticals Inc. Details
6.2.2 Avet Pharmaceuticals Inc. Major Business
6.2.3 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
6.2.4 Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.2.5 Avet Pharmaceuticals Inc. Recent Developments/Updates
6.2.6 Avet Pharmaceuticals Inc. Competitive Strengths & Weaknesses
6.3 Carlsbad Tech
6.3.1 Carlsbad Tech Details
6.3.2 Carlsbad Tech Major Business
6.3.3 Carlsbad Tech Genital Herpes Treatment Drug Product and Services
6.3.4 Carlsbad Tech Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.3.5 Carlsbad Tech Recent Developments/Updates
6.3.6 Carlsbad Tech Competitive Strengths & Weaknesses
6.4 Glenmark Pharmaceuticals Inc.
6.4.1 Glenmark Pharmaceuticals Inc. Details
6.4.2 Glenmark Pharmaceuticals Inc. Major Business
6.4.3 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
6.4.4 Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.4.5 Glenmark Pharmaceuticals Inc. Recent Developments/Updates
6.4.6 Glenmark Pharmaceuticals Inc. Competitive Strengths & Weaknesses
6.5 Zydus Pharmaceuticals
6.5.1 Zydus Pharmaceuticals Details
6.5.2 Zydus Pharmaceuticals Major Business
6.5.3 Zydus Pharmaceuticals Genital Herpes Treatment Drug Product and Services
6.5.4 Zydus Pharmaceuticals Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.5.5 Zydus Pharmaceuticals Recent Developments/Updates
6.5.6 Zydus Pharmaceuticals Competitive Strengths & Weaknesses
6.6 Mylan Pharmaceutcials Inc.
6.6.1 Mylan Pharmaceutcials Inc. Details
6.6.2 Mylan Pharmaceutcials Inc. Major Business
6.6.3 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product and Services
6.6.4 Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.6.5 Mylan Pharmaceutcials Inc. Recent Developments/Updates
6.6.6 Mylan Pharmaceutcials Inc. Competitive Strengths & Weaknesses
6.7 Apotex Inc.
6.7.1 Apotex Inc. Details
6.7.2 Apotex Inc. Major Business
6.7.3 Apotex Inc. Genital Herpes Treatment Drug Product and Services
6.7.4 Apotex Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.7.5 Apotex Inc. Recent Developments/Updates
6.7.6 Apotex Inc. Competitive Strengths & Weaknesses
6.8 Epi Health LLC
6.8.1 Epi Health LLC Details
6.8.2 Epi Health LLC Major Business
6.8.3 Epi Health LLC Genital Herpes Treatment Drug Product and Services
6.8.4 Epi Health LLC Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.8.5 Epi Health LLC Recent Developments/Updates
6.8.6 Epi Health LLC Competitive Strengths & Weaknesses
6.9 AiCuris Anti-infective Cures GmbH
6.9.1 AiCuris Anti-infective Cures GmbH Details
6.9.2 AiCuris Anti-infective Cures GmbH Major Business
6.9.3 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product and Services
6.9.4 AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.9.5 AiCuris Anti-infective Cures GmbH Recent Developments/Updates
6.9.6 AiCuris Anti-infective Cures GmbH Competitive Strengths & Weaknesses
6.10 Chimerix
6.10.1 Chimerix Details
6.10.2 Chimerix Major Business
6.10.3 Chimerix Genital Herpes Treatment Drug Product and Services
6.10.4 Chimerix Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.10.5 Chimerix Recent Developments/Updates
6.10.6 Chimerix Competitive Strengths & Weaknesses
6.11 Admedus
6.11.1 Admedus Details
6.11.2 Admedus Major Business
6.11.3 Admedus Genital Herpes Treatment Drug Product and Services
6.11.4 Admedus Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.11.5 Admedus Recent Developments/Updates
6.11.6 Admedus Competitive Strengths & Weaknesses
6.12 Sanofi Pasteur SA
6.12.1 Sanofi Pasteur SA Details
6.12.2 Sanofi Pasteur SA Major Business
6.12.3 Sanofi Pasteur SA Genital Herpes Treatment Drug Product and Services
6.12.4 Sanofi Pasteur SA Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.12.5 Sanofi Pasteur SA Recent Developments/Updates
6.12.6 Sanofi Pasteur SA Competitive Strengths & Weaknesses
6.13 Maruho Co. Ltd.
6.13.1 Maruho Co. Ltd. Details
6.13.2 Maruho Co. Ltd. Major Business
6.13.3 Maruho Co. Ltd. Genital Herpes Treatment Drug Product and Services
6.13.4 Maruho Co. Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.13.5 Maruho Co. Ltd. Recent Developments/Updates
6.13.6 Maruho Co. Ltd. Competitive Strengths & Weaknesses
6.14 F.Hoffmann-La Roche Ltd.
6.14.1 F.Hoffmann-La Roche Ltd. Details
6.14.2 F.Hoffmann-La Roche Ltd. Major Business
6.14.3 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Product and Services
6.14.4 F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.14.5 F.Hoffmann-La Roche Ltd. Recent Developments/Updates
6.14.6 F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
6.15 Novartis AG
6.15.1 Novartis AG Details
6.15.2 Novartis AG Major Business
6.15.3 Novartis AG Genital Herpes Treatment Drug Product and Services
6.15.4 Novartis AG Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.15.5 Novartis AG Recent Developments/Updates
6.15.6 Novartis AG Competitive Strengths & Weaknesses
6.16 Merck & Co. Inc.
6.16.1 Merck & Co. Inc. Details
6.16.2 Merck & Co. Inc. Major Business
6.16.3 Merck & Co. Inc. Genital Herpes Treatment Drug Product and Services
6.16.4 Merck & Co. Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.16.5 Merck & Co. Inc. Recent Developments/Updates
6.16.6 Merck & Co. Inc. Competitive Strengths & Weaknesses
6.17 GlaxoSmithKline Plc
6.17.1 GlaxoSmithKline Plc Details
6.17.2 GlaxoSmithKline Plc Major Business
6.17.3 GlaxoSmithKline Plc Genital Herpes Treatment Drug Product and Services
6.17.4 GlaxoSmithKline Plc Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022)
6.17.5 GlaxoSmithKline Plc Recent Developments/Updates
6.17.6 GlaxoSmithKline Plc Competitive Strengths & Weaknesses
7 RAW MATERIAL AND INDUSTRY CHAIN
7.1 Raw Material of Genital Herpes Treatment Drug and Key Manufacturers
7.2 Genital Herpes Treatment Drug Manufacturing Costs
7.3 Genital Herpes Treatment Drug Production Process
7.4 Genital Herpes Treatment Drug Industrial Chain
8 DISTRIBUTION CHANNEL ANALYSIS
8.1 Distribution Channel Breakdown for Genital Herpes Treatment Drug Shipments (%): 2017-2028
8.1.1 Direct Channel
8.1.2 Indirect Channel
8.2 Genital Herpes Treatment Drug Typical Distributors
8.3 Genital Herpes Treatment Drug Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Genital Herpes Treatment Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Genital Herpes Treatment Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Genital Herpes Treatment Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Genital Herpes Treatment Drug Market Size Market Share by Region (2017-2022)
Table 5. World Genital Herpes Treatment Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Genital Herpes Treatment Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Genital Herpes Treatment Drug Players in 2021
Table 9. World Genital Herpes Treatment Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Genital Herpes Treatment Drug Company Evaluation Quadrant
Table 11. Head Office of Key Genital Herpes Treatment Drug Player
Table 12. Genital Herpes Treatment Drug Market: Company Product Type Footprint
Table 13. Genital Herpes Treatment Drug Market: Company Product Application Footprint
Table 14. Genital Herpes Treatment Drug Mergers & Acquisitions Activity
Table 15. United States VS China Genital Herpes Treatment Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Genital Herpes Treatment Drug in United States, Headquarters (States, Country)
Table 17. United States Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Genital Herpes Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Genital Herpes Treatment Drug in China, Company Headquarters (Province, Country)
Table 20. China Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Genital Herpes Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Genital Herpes Treatment Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Genital Herpes Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Genital Herpes Treatment Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Genital Herpes Treatment Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Genital Herpes Treatment Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Genital Herpes Treatment Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Genital Herpes Treatment Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Genital Herpes Treatment Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Fresenius Kabi Basic Information, Area Served and Competitors
Table 32. Fresenius Kabi Major Business
Table 33. Fresenius Kabi Genital Herpes Treatment Drug Product and Services
Table 34. Fresenius Kabi Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Fresenius Kabi Recent Developments/Updates
Table 36. Fresenius Kabi Competitive Strengths & Weaknesses
Table 37. Avet Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 38. Avet Pharmaceuticals Inc. Major Business
Table 39. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
Table 40. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Avet Pharmaceuticals Inc. Recent Developments/Updates
Table 42. Avet Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 43. Carlsbad Tech Basic Information, Area Served and Competitors
Table 44. Carlsbad Tech Major Business
Table 45. Carlsbad Tech Genital Herpes Treatment Drug Product and Services
Table 46. Carlsbad Tech Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Carlsbad Tech Recent Developments/Updates
Table 48. Carlsbad Tech Competitive Strengths & Weaknesses
Table 49. Glenmark Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 50. Glenmark Pharmaceuticals Inc. Major Business
Table 51. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
Table 52. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Glenmark Pharmaceuticals Inc. Recent Developments/Updates
Table 54. Glenmark Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 55. Zydus Pharmaceuticals Basic Information, Area Served and Competitors
Table 56. Zydus Pharmaceuticals Major Business
Table 57. Zydus Pharmaceuticals Genital Herpes Treatment Drug Product and Services
Table 58. Zydus Pharmaceuticals Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Zydus Pharmaceuticals Recent Developments/Updates
Table 60. Zydus Pharmaceuticals Competitive Strengths & Weaknesses
Table 61. Mylan Pharmaceutcials Inc. Basic Information, Area Served and Competitors
Table 62. Mylan Pharmaceutcials Inc. Major Business
Table 63. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product and Services
Table 64. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Mylan Pharmaceutcials Inc. Recent Developments/Updates
Table 66. Mylan Pharmaceutcials Inc. Competitive Strengths & Weaknesses
Table 67. Apotex Inc. Basic Information, Area Served and Competitors
Table 68. Apotex Inc. Major Business
Table 69. Apotex Inc. Genital Herpes Treatment Drug Product and Services
Table 70. Apotex Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Apotex Inc. Recent Developments/Updates
Table 72. Apotex Inc. Competitive Strengths & Weaknesses
Table 73. Epi Health LLC Basic Information, Area Served and Competitors
Table 74. Epi Health LLC Major Business
Table 75. Epi Health LLC Genital Herpes Treatment Drug Product and Services
Table 76. Epi Health LLC Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Epi Health LLC Recent Developments/Updates
Table 78. Epi Health LLC Competitive Strengths & Weaknesses
Table 79. AiCuris Anti-infective Cures GmbH Basic Information, Area Served and Competitors
Table 80. AiCuris Anti-infective Cures GmbH Major Business
Table 81. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product and Services
Table 82. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. AiCuris Anti-infective Cures GmbH Recent Developments/Updates
Table 84. AiCuris Anti-infective Cures GmbH Competitive Strengths & Weaknesses
Table 85. Chimerix Basic Information, Area Served and Competitors
Table 86. Chimerix Major Business
Table 87. Chimerix Genital Herpes Treatment Drug Product and Services
Table 88. Chimerix Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Chimerix Recent Developments/Updates
Table 90. Chimerix Competitive Strengths & Weaknesses
Table 91. Admedus Basic Information, Area Served and Competitors
Table 92. Admedus Major Business
Table 93. Admedus Genital Herpes Treatment Drug Product and Services
Table 94. Admedus Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Admedus Recent Developments/Updates
Table 96. Admedus Competitive Strengths & Weaknesses
Table 97. Sanofi Pasteur SA Basic Information, Area Served and Competitors
Table 98. Sanofi Pasteur SA Major Business
Table 99. Sanofi Pasteur SA Genital Herpes Treatment Drug Product and Services
Table 100. Sanofi Pasteur SA Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Sanofi Pasteur SA Recent Developments/Updates
Table 102. Sanofi Pasteur SA Competitive Strengths & Weaknesses
Table 103. Maruho Co. Ltd. Basic Information, Area Served and Competitors
Table 104. Maruho Co. Ltd. Major Business
Table 105. Maruho Co. Ltd. Genital Herpes Treatment Drug Product and Services
Table 106. Maruho Co. Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Maruho Co. Ltd. Recent Developments/Updates
Table 108. Maruho Co. Ltd. Competitive Strengths & Weaknesses
Table 109. F.Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 110. F.Hoffmann-La Roche Ltd. Major Business
Table 111. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Product and Services
Table 112. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. F.Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 114. F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 115. Novartis AG Basic Information, Area Served and Competitors
Table 116. Novartis AG Major Business
Table 117. Novartis AG Genital Herpes Treatment Drug Product and Services
Table 118. Novartis AG Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Novartis AG Recent Developments/Updates
Table 120. Novartis AG Competitive Strengths & Weaknesses
Table 121. Merck & Co. Inc. Basic Information, Area Served and Competitors
Table 122. Merck & Co. Inc. Major Business
Table 123. Merck & Co. Inc. Genital Herpes Treatment Drug Product and Services
Table 124. Merck & Co. Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Merck & Co. Inc. Recent Developments/Updates
Table 126. GlaxoSmithKline Plc Basic Information, Area Served and Competitors
Table 127. GlaxoSmithKline Plc Major Business
Table 128. GlaxoSmithKline Plc Genital Herpes Treatment Drug Product and Services
Table 129. GlaxoSmithKline Plc Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 130. Genital Herpes Treatment Drug Raw Material
Table 131. Key Manufacturers of Genital Herpes Treatment Drug Raw Materials
Table 132. Genital Herpes Treatment Drug Typical Distributors
Table 133. Genital Herpes Treatment Drug Typical Customers
Table 1. World Genital Herpes Treatment Drug Market Size by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Genital Herpes Treatment Drug Market Size by Region (2017-2022) & (USD Million)
Table 3. World Genital Herpes Treatment Drug Market Size by Region (2023-2028) & (USD Million)
Table 4. World Genital Herpes Treatment Drug Market Size Market Share by Region (2017-2022)
Table 5. World Genital Herpes Treatment Drug Market Size Market Share by Region (2023-2028)
Table 6. Major Market Trends
Table 7. World Genital Herpes Treatment Drug Revenue by Player (2017-2022) & (USD Million)
Table 8. Revenue Market Share of Key Genital Herpes Treatment Drug Players in 2021
Table 9. World Genital Herpes Treatment Drug Industry Rank of Major Player, Based on Revenue in 2021
Table 10. Global Genital Herpes Treatment Drug Company Evaluation Quadrant
Table 11. Head Office of Key Genital Herpes Treatment Drug Player
Table 12. Genital Herpes Treatment Drug Market: Company Product Type Footprint
Table 13. Genital Herpes Treatment Drug Market: Company Product Application Footprint
Table 14. Genital Herpes Treatment Drug Mergers & Acquisitions Activity
Table 15. United States VS China Genital Herpes Treatment Drug Market Size Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 16. Major Player of Genital Herpes Treatment Drug in United States, Headquarters (States, Country)
Table 17. United States Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 18. United States Genital Herpes Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 19. Major Player of Genital Herpes Treatment Drug in China, Company Headquarters (Province, Country)
Table 20. China Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 21. China Genital Herpes Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 22. Major Player of Genital Herpes Treatment Drug in Rest of World, Company Headquarters (State, Country)
Table 23. Rest of World Genital Herpes Treatment Drug Revenue by Domestic Player, (2017-2022) & (USD Million)
Table 24. Rest of World Genital Herpes Treatment Drug Revenue Market Share by Domestic Player, (2017-2022)
Table 25. World Genital Herpes Treatment Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 26. World Genital Herpes Treatment Drug Revenue by Type (2017-2022) & (USD Million)
Table 27. World Genital Herpes Treatment Drug Revenue by Type (2023-2028) & (USD Million)
Table 28. World Genital Herpes Treatment Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 29. World Genital Herpes Treatment Drug Revenue by Application (2017-2022) & (USD Million)
Table 30. World Genital Herpes Treatment Drug Revenue by Application (2023-2028) & (USD Million)
Table 31. Fresenius Kabi Basic Information, Area Served and Competitors
Table 32. Fresenius Kabi Major Business
Table 33. Fresenius Kabi Genital Herpes Treatment Drug Product and Services
Table 34. Fresenius Kabi Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 35. Fresenius Kabi Recent Developments/Updates
Table 36. Fresenius Kabi Competitive Strengths & Weaknesses
Table 37. Avet Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 38. Avet Pharmaceuticals Inc. Major Business
Table 39. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
Table 40. Avet Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 41. Avet Pharmaceuticals Inc. Recent Developments/Updates
Table 42. Avet Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 43. Carlsbad Tech Basic Information, Area Served and Competitors
Table 44. Carlsbad Tech Major Business
Table 45. Carlsbad Tech Genital Herpes Treatment Drug Product and Services
Table 46. Carlsbad Tech Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 47. Carlsbad Tech Recent Developments/Updates
Table 48. Carlsbad Tech Competitive Strengths & Weaknesses
Table 49. Glenmark Pharmaceuticals Inc. Basic Information, Area Served and Competitors
Table 50. Glenmark Pharmaceuticals Inc. Major Business
Table 51. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Product and Services
Table 52. Glenmark Pharmaceuticals Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 53. Glenmark Pharmaceuticals Inc. Recent Developments/Updates
Table 54. Glenmark Pharmaceuticals Inc. Competitive Strengths & Weaknesses
Table 55. Zydus Pharmaceuticals Basic Information, Area Served and Competitors
Table 56. Zydus Pharmaceuticals Major Business
Table 57. Zydus Pharmaceuticals Genital Herpes Treatment Drug Product and Services
Table 58. Zydus Pharmaceuticals Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 59. Zydus Pharmaceuticals Recent Developments/Updates
Table 60. Zydus Pharmaceuticals Competitive Strengths & Weaknesses
Table 61. Mylan Pharmaceutcials Inc. Basic Information, Area Served and Competitors
Table 62. Mylan Pharmaceutcials Inc. Major Business
Table 63. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Product and Services
Table 64. Mylan Pharmaceutcials Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 65. Mylan Pharmaceutcials Inc. Recent Developments/Updates
Table 66. Mylan Pharmaceutcials Inc. Competitive Strengths & Weaknesses
Table 67. Apotex Inc. Basic Information, Area Served and Competitors
Table 68. Apotex Inc. Major Business
Table 69. Apotex Inc. Genital Herpes Treatment Drug Product and Services
Table 70. Apotex Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 71. Apotex Inc. Recent Developments/Updates
Table 72. Apotex Inc. Competitive Strengths & Weaknesses
Table 73. Epi Health LLC Basic Information, Area Served and Competitors
Table 74. Epi Health LLC Major Business
Table 75. Epi Health LLC Genital Herpes Treatment Drug Product and Services
Table 76. Epi Health LLC Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 77. Epi Health LLC Recent Developments/Updates
Table 78. Epi Health LLC Competitive Strengths & Weaknesses
Table 79. AiCuris Anti-infective Cures GmbH Basic Information, Area Served and Competitors
Table 80. AiCuris Anti-infective Cures GmbH Major Business
Table 81. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Product and Services
Table 82. AiCuris Anti-infective Cures GmbH Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 83. AiCuris Anti-infective Cures GmbH Recent Developments/Updates
Table 84. AiCuris Anti-infective Cures GmbH Competitive Strengths & Weaknesses
Table 85. Chimerix Basic Information, Area Served and Competitors
Table 86. Chimerix Major Business
Table 87. Chimerix Genital Herpes Treatment Drug Product and Services
Table 88. Chimerix Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 89. Chimerix Recent Developments/Updates
Table 90. Chimerix Competitive Strengths & Weaknesses
Table 91. Admedus Basic Information, Area Served and Competitors
Table 92. Admedus Major Business
Table 93. Admedus Genital Herpes Treatment Drug Product and Services
Table 94. Admedus Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 95. Admedus Recent Developments/Updates
Table 96. Admedus Competitive Strengths & Weaknesses
Table 97. Sanofi Pasteur SA Basic Information, Area Served and Competitors
Table 98. Sanofi Pasteur SA Major Business
Table 99. Sanofi Pasteur SA Genital Herpes Treatment Drug Product and Services
Table 100. Sanofi Pasteur SA Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 101. Sanofi Pasteur SA Recent Developments/Updates
Table 102. Sanofi Pasteur SA Competitive Strengths & Weaknesses
Table 103. Maruho Co. Ltd. Basic Information, Area Served and Competitors
Table 104. Maruho Co. Ltd. Major Business
Table 105. Maruho Co. Ltd. Genital Herpes Treatment Drug Product and Services
Table 106. Maruho Co. Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 107. Maruho Co. Ltd. Recent Developments/Updates
Table 108. Maruho Co. Ltd. Competitive Strengths & Weaknesses
Table 109. F.Hoffmann-La Roche Ltd. Basic Information, Area Served and Competitors
Table 110. F.Hoffmann-La Roche Ltd. Major Business
Table 111. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Product and Services
Table 112. F.Hoffmann-La Roche Ltd. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 113. F.Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 114. F.Hoffmann-La Roche Ltd. Competitive Strengths & Weaknesses
Table 115. Novartis AG Basic Information, Area Served and Competitors
Table 116. Novartis AG Major Business
Table 117. Novartis AG Genital Herpes Treatment Drug Product and Services
Table 118. Novartis AG Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 119. Novartis AG Recent Developments/Updates
Table 120. Novartis AG Competitive Strengths & Weaknesses
Table 121. Merck & Co. Inc. Basic Information, Area Served and Competitors
Table 122. Merck & Co. Inc. Major Business
Table 123. Merck & Co. Inc. Genital Herpes Treatment Drug Product and Services
Table 124. Merck & Co. Inc. Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 125. Merck & Co. Inc. Recent Developments/Updates
Table 126. GlaxoSmithKline Plc Basic Information, Area Served and Competitors
Table 127. GlaxoSmithKline Plc Major Business
Table 128. GlaxoSmithKline Plc Genital Herpes Treatment Drug Product and Services
Table 129. GlaxoSmithKline Plc Genital Herpes Treatment Drug Revenue, Gross Margin and Market Share (2017-2022) & (USD Million)
Table 130. Genital Herpes Treatment Drug Raw Material
Table 131. Key Manufacturers of Genital Herpes Treatment Drug Raw Materials
Table 132. Genital Herpes Treatment Drug Typical Distributors
Table 133. Genital Herpes Treatment Drug Typical Customers
LIST OF FIGURES
Figure 1. Genital Herpes Treatment Drug Picture
Figure 2. World Genital Herpes Treatment Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Genital Herpes Treatment Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Genital Herpes Treatment Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 12. Genital Herpes Treatment Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Genital Herpes Treatment Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Genital Herpes Treatment Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Genital Herpes Treatment Drug Markets in 2021
Figure 17. United States VS China: Genital Herpes Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Genital Herpes Treatment Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Genital Herpes Treatment Drug Market Size Market Share by Type in 2021
Figure 20. Acyclovir (Zovirax)
Figure 21. Famciclovir (Famvir)
Figure 22. Valacyclovir (Valtrex)
Figure 23. Others
Figure 24. World Genital Herpes Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 25. World Genital Herpes Treatment Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Genital Herpes Treatment Drug Market Size Market Share by Application in 2021
Figure 27. Hospital
Figure 28. Clinic
Figure 29. Others
Figure 30. World Genital Herpes Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Genital Herpes Treatment Drug in 2021
Figure 32. Manufacturing Process Analysis of Genital Herpes Treatment Drug
Figure 33. Genital Herpes Treatment Drug Industrial Chain
Figure 34. Distribution Channel Breakdown for Genital Herpes Treatment Drug Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
Figure 1. Genital Herpes Treatment Drug Picture
Figure 2. World Genital Herpes Treatment Drug Total Market Size: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Genital Herpes Treatment Drug Total Market Size (2017-2028) & (USD Million)
Figure 4. World Genital Herpes Treatment Drug Market Size Market Share by Region (2017-2028)
Figure 5. United States Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 6. China Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 7. Europe Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 8. Japan Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 9. South Korea Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 10. ASEAN Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 11. India Genital Herpes Treatment Drug Market Size (2017-2028) & (USD Million)
Figure 12. Genital Herpes Treatment Drug Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. Producer Shipments of Genital Herpes Treatment Drug by Player Revenue ($MM) and Market Share (%): 2021
Figure 15. Global Four-firm Concentration Ratios (CR4) for Genital Herpes Treatment Drug Markets in 2021
Figure 16. Global Four-firm Concentration Ratios (CR8) for Genital Herpes Treatment Drug Markets in 2021
Figure 17. United States VS China: Genital Herpes Treatment Drug Market Size Market Share Comparison (2017 & 2021 & 2028)
Figure 18. World Genital Herpes Treatment Drug Market Size by Type, (USD Million), 2017 & 2021 & 2028
Figure 19. World Genital Herpes Treatment Drug Market Size Market Share by Type in 2021
Figure 20. Acyclovir (Zovirax)
Figure 21. Famciclovir (Famvir)
Figure 22. Valacyclovir (Valtrex)
Figure 23. Others
Figure 24. World Genital Herpes Treatment Drug Market Size Market Share by Type (2017-2028)
Figure 25. World Genital Herpes Treatment Drug Market Size by Application, (USD Million), 2017 & 2021 & 2028
Figure 26. World Genital Herpes Treatment Drug Market Size Market Share by Application in 2021
Figure 27. Hospital
Figure 28. Clinic
Figure 29. Others
Figure 30. World Genital Herpes Treatment Drug Market Size Market Share by Application (2017-2028)
Figure 31. Manufacturing Cost Structure Analysis of Genital Herpes Treatment Drug in 2021
Figure 32. Manufacturing Process Analysis of Genital Herpes Treatment Drug
Figure 33. Genital Herpes Treatment Drug Industrial Chain
Figure 34. Distribution Channel Breakdown for Genital Herpes Treatment Drug Shipments (%): 2017-2028
Figure 35. Direct Channel Pros & Cons
Figure 36. Indirect Channel Pros & Cons
Figure 37. Methodology
Figure 38. Research Process and Data Source
